Efficacy, safety and pharmacokinetics of 3 doses of REC 0/0059 (MT8) eye-drops for the treatment of stage 2 (moderate) and 3 (severe) neurotrophic keratitis in adult patients (estudio RECORDATI)

Efficacy, safety and pharmacokinetics of 3 doses of REC 0/0059 (MT8) eye-drops for the treatment of stage 2 (moderate) and 3 (severe) neurotrophic keratitis in adult patients (estudio RECORDATI)

No Comments

Sorry, the comment form is closed at this time.